Media Release | MCH Group | Masterpiece London MCH Group

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
165
Media Release | MCH Group | Masterpiece London

MCH Group expanding its position in key global collectors' markets

  • MCH Group acquires the collectors' event Masterpiece London.
  • Alignment of the organisational structure to corporate development.
  • CFO Christophe Biollaz is leaving the MCH Group next year.
  • Change in the management of Design & Regional Art Fairs.

MCH Group, one of the world's leading live marketing companies, which has its head office in Basel/Switzerland, is expanding its international exhibition portfolio and strengthening its position in exclusive global collectors' markets. At the same time, the group is gearing its organisational structure even more consistently to the implementation of its corporate strategy.

Acquisition of Masterpiece London Ltd

On 30 November 2017, MCH Group Ltd. acquired 67.5% of the shares in Masterpiece London Ltd, which organises the collectors' event of this same name at the Royal Hospital Chelsea in London each summer. The remaining 32.5% of the shares are held by the current shareholders.

Masterpiece London Ltd was founded in 2008, the first edition of the fair was in 2010. At the fair, 150 leading galleries and specialists present to new and established collectors exceptional works of art from every major market discipline, including ancient and contemporary art, rare books and photography, design and antiques, jewellery and ceramics. Masterpiece London is one of the leading events of its kind globally today. The ten-strong team is managed by Lucie Kitchener. She joined Masterpiece London in January 2017 having previously held senior roles in the luxury goods sector. As managing director, she will be responsible for the new business unit within MCH Group.

With the integration of Masterpiece London, MCH Group is further expanding its already strong position in the key global collectors' markets. Presenting the finest works of art from antiquity to the present day, and with a unique focus on cross-collecting, Masterpiece London ideally complements MCH's collector events portfolio with Art Basel (in Basel, Miami Beach and Hong Kong), the Design & Regional Art Fairs and the newly launched Grand Basel for exclusive automobiles, which opened in Basel in 2018. Masterpiece London and Grand Basel will be staged at further locations in the USA, Asia and the Middle East over the next few years.

Alignment of the organisational structure

The MCH Group is realigning its organisational structure so as to better support the implementation of its corporate strategy and the requirements of increasing digitisation. The international exhibition and event business (Baselworld, Art Basel, Design & Regional Art Fairs, Grand Basel and Masterpiece London) is being grouped together in the "Global Events" division under the management of CEO René Kamm. The national exhibition and event business at the Basel, Zurich and Lausanne locations - the MCH exhibition portfolio under the management of Didier Peier and the supervision of third-party events and facility management - are being grouped together in the "Events Switzerland & Venues" division under the management of Peter Holenstein. Jean-Marc Devaud continues to lead the division "Live Marketing Solutions".

The fields of New Products and M&A, Digital Business and Services and ICT and Human Resources are being pooled in the extended service unit "Corporate Development & Services" under the management of Stephan Peyer. The Chief Financial Officer (CFO) - the head of "Finance & Administration" to date - will be concentrating on the functions of "Corporate Finance" and also "Risk Management" and "M&A Support" in future.

With these structural alignments it will be possible to create and exploit further synergies, both in the development of international business activity and in strengthening national MCH and third-party exhibitions.

CFO Christophe Biollaz is leaving the MCH Group

Christophe Biollaz, Head of Finance & Administration and a member of the Executive Board, has taken the decision to leave the MCH Group in the course of the coming year, at his own request, and to take up new professional challenges. He joined the company on 1 December 2013 and has held the post of Chief Financial Officer (CFO) since 1 January 2014. The Board of Directors and management greatly regret the forthcoming departure of Christophe Biollaz. They would like to thank him for his high-level commitment and the valuable inputs he has contributed to the MCH Group over the past four years, and especially for boosting the group's financial competence and for his active participation in the strategic realignment of the company. He will be continuing in his function until a successor has been arranged and will ensure a smooth transition.

New management of Design & Regional Art Fairs

Marco Fazzone, Managing Director of Design & Regional Art Fairs, will be leaving MCH Group at his own request at the end of January 2018 and taking on a new professional challenge. From 2013 to 2016, Marco Fazzone formed part of the management team for Art Basel, before taking charge of the new Design & Regional Art Fairs business unit with responsibility for developing the portfolio of regional art fairs. MCH Group very much regrets the departure of Marco Fazzone and thanks him for the excellent basis that he has created for the further development of the regional art fairs. Frank Lasry will be the new managing director of the Design & Regional Art Fairs business unit as of 1 February 2018. Since 2014, he has been Chief Operating Officer (COO) at Phillips Auctioneers Ltd and, prior to this, held various operational and managerial positions at Christie's International in London, Paris, Hong Kong and Dubai for 12 years.

Further Information

MCH Newsroom

www.mch-group.com

www.masterpiecefair.com

Contact

MCH Group Christian Jecker Corporate Communications +41 58 206 22 52 christian.jecker@mch-group.com www.mch-group.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...79504c9b91

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

A Closer Look at Marvell Tech's Upcoming Earnings Release

Updated Category News Views 184

Marvell Tech's Expected Earnings Release Marvell Tech (NASDAQ: MRVL) is set to announce its latest quarterly earnings in December. As investors await this critical financial moment, a brief review of what to expect can shed light on potential impacts and opportunities. Analysts' Earnings Projections Analysts forecast that Marvell Tech will achieve an earnings per share...

Continue Reading
Banijay Group's Recent Share Transactions Update and Insights

Updated Category News Views 222

Recent Share Transactions Overview Banijay Group N.V. (ISIN: NL0015000X07, Bloomberg: BNJ NA, Reuters: BNJ.AS) has reported on its recent share transactions, showcasing the buying and selling activities from the period of September 22 to September 26. Understanding Share Transactions During this timeframe, a mix of buying and selling occurred within the company’s...

Continue Reading
Strategic Growth for Voyageur Mineral Explorers via New Offering

Updated Category News Views 143

Voyageur Mineral Explorers Corp. Secures Massive Funding Voyageur Mineral Explorers Corp. (CSE: VOY) has recently made headlines by completing a significant brokered offering, raising $37.5 million. This financial boost comes at a crucial time for the Company as it seeks to expand its operations and investments in the mineral exploration sector. The offering was executed...

Continue Reading
Applied Materials Faces Challenges Amid Weak Outlook and Stocks

Updated Category News Views 114

Applied Materials Inc. Stock Performance Applied Materials Inc. (NASDAQ: AMAT) recently experienced a noticeable decline in its stock value as the company shared its financial results. After the market closure, the organization revealed its third-quarter earnings, leading to significant concern among investors. The stock's value tumbled, reflecting the market's reaction...

Continue Reading
VFC Class Action Demands Attention: Key Details for Investors

Updated Category News Views 192

Understanding the VFC Class Action Lawsuit Investors in V.F. Corporation, commonly known as VFC, should pay close attention to a pending class action lawsuit that could have significant implications. The law firm Faruqi & Faruqi, a reputable name in securities litigation, has stepped forward to represent affected investors. They are drawing attention to a critical...

Continue Reading